Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers

Ovarian cancer represents the most lethal tumor type among malignancies of the female reproductive system. Overall survival rates remain low. In this study, we identify the serine protease inhibitor Kazal type 1 (SPINK1) as a potential therapeutic target for a subset of ovarian cancers. We show that...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Mehner, Christine, Oberg, Ann L., Kalli, Kimberly R., Nassar, Aziza, Hockla, Alexandra, Pendlebury, Devon, Cichon, Magdalena A., Goergen, Krista M., Maurer, Matthew J., Goode, Ellen L., Keeney, Gary L., Jatoi, Aminah, Sahin-Tóth, Miklós, Copland, John A., Radisky, Derek C., Radisky, Evette S.
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2015
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742138/
https://ncbi.nlm.nih.gov/pubmed/26437224
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы